Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.
Also called NCT05337241
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 130 participants
- Sponsor
- Thermedical, Inc.
- Registry
-
NCT05337241
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05337241. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-09 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
- Condition
- Refractory Ventricular Tachycardia
- Intervention (Device)
- Saline Enhanced Radiofrequency (SERF) Ablation
- Lead sponsor
- Thermedical, Inc.
Record details
- Record id
cardio:ct-nct05337241- Content hash
8620e26721b683a8455b8fc71635669e651212c7a02365e2f8408e50c6c0885c